ISpecimen Correlations

ISPC Stock  USD 1.66  0.05  3.11%   
The correlation of ISpecimen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

ISpecimen Correlation With Market

ISpecimenDowDiversified AwayISpecimenDowDiversified Away100%

Good diversification

The correlation between iSpecimen and DJI is -0.07 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding iSpecimen and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iSpecimen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade ISpecimen Stock refer to our How to Trade ISpecimen Stock guide.

Moving together with ISpecimen Stock

  0.7ILMN Illumina Sell-off TrendPairCorr
  0.78INZY Inozyme PharmaPairCorr
  0.83KURA Kura OncologyPairCorr
  0.95ABOS Acumen PharmaceuticalsPairCorr
  0.94ADTX Aditxt IncPairCorr
  0.84STRO Sutro BiopharmaPairCorr
  0.92TCRX Tscan TherapeuticsPairCorr
  0.84TERN Terns PharmaceuticalsPairCorr
  0.89CRNX Crinetics Pharmaceuticals Buyout TrendPairCorr
  0.73CTMX CytomX TherapeuticsPairCorr
  0.7DAWN Day One BiopharmaceuPairCorr
  0.74TLKMF Telkom Indonesia TbkPairCorr

Moving against ISpecimen Stock

  0.79OPT OptheaPairCorr
  0.71LTRN Lantern PharmaPairCorr
  0.7PHGE Biomx IncPairCorr
  0.69FENC Fennec PharmaceuticalsPairCorr
  0.67GANX Gain TherapeuticsPairCorr
  0.6PFE Pfizer IncPairCorr
  0.57CUE Cue BiopharmaPairCorr
  0.63DBVT DBV Technologies Earnings Call This WeekPairCorr
  0.55CGTX Cognition TherapeuticsPairCorr
  0.37CPRX Catalyst PharmaceuticalsPairCorr
  0.88OBI Ondine BiomedicalPairCorr
  0.85SSNLF Samsung ElectronicsPairCorr
  0.74GPI Group 1 AutomotivePairCorr
  0.71EC Ecopetrol SA ADR Sell-off TrendPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
CSTLFONR
TRIBFONR
TRIBCSTL
XGNFONR
XGNCSTL
TRIBOCX
  
High negative correlations   
PSNLOCX
PSNLFONR
TRIBPSNL
PSNLXGN
PSNLCSTL
OCXXGN

Risk-Adjusted Indicators

There is a big difference between ISpecimen Stock performing well and ISpecimen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ISpecimen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
GTH  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
OLK  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
FONR  1.26 (0.13) 0.00 (0.24) 0.00 
 2.50 
 10.83 
CSTL  2.26 (0.38) 0.00  14.85  0.00 
 3.79 
 23.12 
XGN  5.13  0.18  0.02  0.05  6.44 
 15.86 
 45.67 
OCX  2.84  0.15  0.05  0.52  2.88 
 7.56 
 23.66 
PSNL  5.48  0.67  0.11  0.16  5.18 
 9.82 
 60.83 
IDXG  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
TRIB  5.35 (0.35) 0.00 (1.35) 0.00 
 11.25 
 108.49 
HTGM  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

ISpecimen Corporate Management